Agency Forms Undergoing Paperwork Reduction Act Review, 17553-17554 [E7-6583]

Download as PDF sroberts on PROD1PC70 with NOTICES Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices agreement and the comments received, and will decide whether it should withdraw from the agreement or make final the agreement’s proposed order. Respondents, through subsidiaries, own and operate several restaurant chains, including Olive Garden Restaurant, Red Lobster Restaurant, Smokey Bones Restaurant, and Bahama Breeze Restaurant. Respondents advertise, sell, and distribute Darden Gift Cards through their restaurants and Web sites, and third parties. Darden Gift Cards are plastic, stored-value cards, similar in size and shape to credit or debit cards, often branded with one or more of Darden’s restaurant logos. Darden Gift Cards typically can be used to purchase goods or services at any of Darden’s restaurant locations. This matter concerns the respondents’ alleged failure to disclose, or failure to disclose adequately, material terms and conditions of Darden Gift Cards. The Commission’s complaint alleges that, in the advertising and sale of Darden Gift Cards, respondents have represented, expressly or by implication, that a consumer can redeem a Darden Gift Card for goods or services of an equal value to the monetary amount placed on the card. Respondents have failed to disclose, or failed to disclose adequately, that, after a specified number of consecutive months of non-use (i.e., 15 or 24 months), respondents deduct a $1.50 fee per month from the value of the Darden Gift Card until it is used again. The proposed complaint alleges that the failure to disclose adequately this material fact is a deceptive practice. The proposed consent order contains provisions designed to prevent respondents from engaging in similar acts and practices in the future. Part I.A. of the proposed order prohibits respondents from advertising or selling Darden Gift Cards without disclosing, clearly and prominently: (a) The existence of any expiration date or automatic fees, in all advertising, and (b) all material terms and conditions of any expiration date or automatic fee, at the point of sale and prior to purchase. The effect of this provision is to require respondents to alert consumers to potential fees and expiration dates during advertising, and to fully disclose all relevant details at the point of sale, before consumers purchase the gift cards. Part I.B. of the proposed order prohibits respondents from advertising or selling Darden Gift Cards without disclosing, clearly and prominently the existence of any automatic fee or expiration date on the front of the gift card. VerDate Aug<31>2005 18:21 Apr 06, 2007 Jkt 211001 Part II of the proposed order prohibits respondents from making any misrepresentation about any material term or condition associated with the Darden Gift Card. Part III.A. of the proposed order prohibits respondents from collecting or attempting to collect any dormancy fee on any Darden Gift Card activated prior to the date of issuance of the proposed order. Part III.B. of the proposed order requires respondents, upon issuance of the order, to cause the amount of any fees assessed on a Darden Gift Card prior to the date of issuance of the order to be restored to the card. Part III.C. of the proposed order requires respondents to provide notice to consumers of the automatic restoration of fees required by Section III.B. This notice must be clearly and prominently disclosed on respondents’ websites, including https:// www.darden.com, https:// www.dardenrestaurants.com, https:// www.redlobster.com, https:// www.olivegarden.com, https:// www.smokeybones.com, and https:// www.bahamabreeze.com. Part IV of the proposed order contains a document retention requirement, the purpose of which is to ensure compliance with the proposed order. It requires that respondents maintain accounting and sales records for Darden Gift Cards, copies of ads and promotional material that contain representations covered by the proposed order, complaints and refund requests relating to the Darden Gift Cards, and other materials that were relied upon by respondents in complying with the proposed order. Part V of the proposed order requires respondents to distribute copies of the order to various principals, officers, directors, and managers of respondents as well as to the officers, directors, and managers of any third-party vendor who engages in conduct related to the proposed order. Part VI of the proposed order requires respondents to notify the Commission of any changes in corporate structure that might affect compliance with the order. Part VII of the proposed order requires respondents to file with the Commission one or more reports detailing compliance with the order. Part VIII of the proposed order is a ‘‘sunset’’ provision, dictating the conditions under which the order will terminate twenty years from the date it is issued or twenty years after a complaint is filed in Federal court, by either the United States or the FTC, alleging any violation of the order. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 17553 The purpose of this analysis is to facilitate public comment on the proposed order. It is not intended to constitute an official interpretation of the proposed order or to modify in any way its terms. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. E7–6610 Filed 4–6–07; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–07–06AX] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Risk Perception, Worry, and Use of Ovarian Cancer Screening Among Women At High, Elevated, and Average Risk of Ovarian Cancer—NEW— National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Accounting for an estimated 22,220 cases and 16,210 deaths in 2005, ovarian cancer is the most frequent cause of death from gynecologic malignancy in the United States. In over 80 percent of patients, ovarian cancer presents at a late clinical stage, affording a five-year survival rate of only 28 percent. For cases where ovarian cancer is identified in Stage I, however, the five-year survival rate exceeds 90 percent. Identifying a woman’s risk of ovarian cancer plays a large role in determining the appropriateness of having her undergo screening. It is only for women with a strong family history of ovarian and/or breast cancer or women with a E:\FR\FM\09APN1.SGM 09APN1 17554 Federal Register / Vol. 72, No. 67 / Monday, April 9, 2007 / Notices hereditary genetic risk for ovarian cancer that the currently available screening modalities of CA 125 and transvaginal ultrasound are recommended. Statements from the scientific and medical community regarding recommendations for ovarian cancer screening play only a partial role in a woman’s decision to undergo screening exams. Numerous psychological and sociological factors can affect this decision as well, including a woman’s knowledge, attitudes, beliefs, and experiences. For instance, a woman’s experience of cancer within her family or experience with a friend who has had cancer may influence a woman’s screening decisions. The literature also notes that women with a family history of ovarian cancer report increased worry and high levels of perceived risk. A positive association has also been shown between screening behavior and family history. Recent studies indicate, however, that screening is not occurring in proportion to women’s levels of risk. These findings underscore the need for a better understanding of how perceived risk of ovarian cancer may influence worry about cancer and ultimately screening behavior. To address these issues, the Division of Cancer Prevention and Control (DCPC), at the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, is conducting a study to examine the effects of family history of cancer, knowledge about ovarian cancer, worry and/or anxiety, and perceived risk of cancer on the likelihood of a woman undergoing screening for ovarian cancer. By also examining other psycho-social factors such as a woman’s closeness to a relative or friend with cancer, coping style, cancer worry, use of other cancer screening tests, social support, and provider’s recommendations, the study will elucidate the causal pathway leading from actual risk (as measured by family history) through perceived risk to intent to undergo screening and actual screening behavior. The proposed study will consist of two tasks. In Task 1, a baseline survey will be administered through a computer-assisted telephone interview (CATI) program. Initially, an estimated 32,000 women will be screened to determine eligibility, and then approximately 2000 women will be asked a series of questions over a 35minute time period. Questions will cover key variables related to ovarian cancer screening including coping, anxiety, perceived risk, worry, personal cancer history, family cancer history, closeness with family or friends who have had cancer, screening behavior, and knowledge of ovarian cancer. In Task 2, a follow-up questionnaire will be administered, also using a CATI program, to approximately 1600 of the women included in the baseline questionnaire. Each of the women will be contacted one year after they complete the baseline survey. The researchers anticipate a 15 percent attrition of the sample between baseline and follow-up. In the follow-up, women will be asked a series of questions over a 15-minute time period. The purpose of this data collection effort is to determine if risk perception has changed and to ask about screening for ovarian cancer, since the baseline questionnaire was administered. All data will be collected over a threeyear time period. The total estimated annualized burden hours are 1,411. There are no costs to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS No. of respondents Group Type of respondents Eligibility Screener .......................................... Baseline Survey .............................................. Women 30 and older ..................................... Women 30 and older (high, elevated or average risk of ovarian cancer). Women who completed the baseline survey Follow-Up Survey ............................................ DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P sroberts on PROD1PC70 with NOTICES Dated: April 3, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–6583 Filed 4–6–07; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Arthritis and Disability: Biracial Cohort Study of Knee and Hip Osteoarthritis, Potential Extramural Project (PEP) 2007–R–06 and Evaluating Sustainable Delivery Systems for Arthritis Intervention Programs, PEP 2007–R–08 Centers for Disease Control and Prevention In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned SEP. Time and Date: 12 p.m.–4 p.m., May 14, 2007 (Closed). Place: Teleconference. VerDate Aug<31>2005 18:21 Apr 06, 2007 Jkt 211001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 No. of responses per respondent Avg. burden per response (in hours) 10,667 667 1 1 5/60 35/60 533 1 15/60 Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Arthritis and Disability: Biracial Cohort Study of Knee and Hip Osteoarthritis,’’ Potential Extramural Project (PEP) 2007–R–06 and ‘‘Evaluating Sustainable Delivery Systems for Arthritis Intervention Programs,’’ PEP 2007– R–08. For Further Information Contact: Juliana Cyril, M.P.H., Ph.D., CDC, 1600 Clifton Road NE, Mailstop D–72, Atlanta, GA 30333, Telephone (404) 639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 72, Number 67 (Monday, April 9, 2007)]
[Notices]
[Pages 17553-17554]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6583]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-07-06AX]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Risk Perception, Worry, and Use of Ovarian Cancer Screening Among 
Women At High, Elevated, and Average Risk of Ovarian Cancer--NEW--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Accounting for an estimated 22,220 cases and 16,210 deaths in 2005, 
ovarian cancer is the most frequent cause of death from gynecologic 
malignancy in the United States. In over 80 percent of patients, 
ovarian cancer presents at a late clinical stage, affording a five-year 
survival rate of only 28 percent. For cases where ovarian cancer is 
identified in Stage I, however, the five-year survival rate exceeds 90 
percent.
    Identifying a woman's risk of ovarian cancer plays a large role in 
determining the appropriateness of having her undergo screening. It is 
only for women with a strong family history of ovarian and/or breast 
cancer or women with a

[[Page 17554]]

hereditary genetic risk for ovarian cancer that the currently available 
screening modalities of CA 125 and transvaginal ultrasound are 
recommended.
    Statements from the scientific and medical community regarding 
recommendations for ovarian cancer screening play only a partial role 
in a woman's decision to undergo screening exams. Numerous 
psychological and sociological factors can affect this decision as 
well, including a woman's knowledge, attitudes, beliefs, and 
experiences. For instance, a woman's experience of cancer within her 
family or experience with a friend who has had cancer may influence a 
woman's screening decisions.
    The literature also notes that women with a family history of 
ovarian cancer report increased worry and high levels of perceived 
risk. A positive association has also been shown between screening 
behavior and family history. Recent studies indicate, however, that 
screening is not occurring in proportion to women's levels of risk. 
These findings underscore the need for a better understanding of how 
perceived risk of ovarian cancer may influence worry about cancer and 
ultimately screening behavior.
    To address these issues, the Division of Cancer Prevention and 
Control (DCPC), at the National Center for Chronic Disease Prevention 
and Health Promotion, Centers for Disease Control and Prevention, is 
conducting a study to examine the effects of family history of cancer, 
knowledge about ovarian cancer, worry and/or anxiety, and perceived 
risk of cancer on the likelihood of a woman undergoing screening for 
ovarian cancer. By also examining other psycho-social factors such as a 
woman's closeness to a relative or friend with cancer, coping style, 
cancer worry, use of other cancer screening tests, social support, and 
provider's recommendations, the study will elucidate the causal pathway 
leading from actual risk (as measured by family history) through 
perceived risk to intent to undergo screening and actual screening 
behavior.
    The proposed study will consist of two tasks. In Task 1, a baseline 
survey will be administered through a computer-assisted telephone 
interview (CATI) program. Initially, an estimated 32,000 women will be 
screened to determine eligibility, and then approximately 2000 women 
will be asked a series of questions over a 35-minute time period. 
Questions will cover key variables related to ovarian cancer screening 
including coping, anxiety, perceived risk, worry, personal cancer 
history, family cancer history, closeness with family or friends who 
have had cancer, screening behavior, and knowledge of ovarian cancer.
    In Task 2, a follow-up questionnaire will be administered, also 
using a CATI program, to approximately 1600 of the women included in 
the baseline questionnaire. Each of the women will be contacted one 
year after they complete the baseline survey. The researchers 
anticipate a 15 percent attrition of the sample between baseline and 
follow-up. In the follow-up, women will be asked a series of questions 
over a 15-minute time period. The purpose of this data collection 
effort is to determine if risk perception has changed and to ask about 
screening for ovarian cancer, since the baseline questionnaire was 
administered.
    All data will be collected over a three-year time period. The total 
estimated annualized burden hours are 1,411. There are no costs to the 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      No. of        Avg. burden
                 Group                     Type of respondents        No. of       responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Eligibility Screener..................  Women 30 and older......          10,667               1            5/60
Baseline Survey.......................  Women 30 and older                   667               1           35/60
                                         (high, elevated or
                                         average risk of ovarian
                                         cancer).
Follow-Up Survey......................  Women who completed the              533               1           15/60
                                         baseline survey.
----------------------------------------------------------------------------------------------------------------


    Dated: April 3, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E7-6583 Filed 4-6-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.